Managed Entry Agreements: The confidentiality issue
Managed Entry Agreements (MEAs) are contracts between pharmaceutical companies/…
For idiopathic pulmonary fibrosis treatment, a brighter future could be only a breath away
An overview of the disease Idiopathic pulmonary fibrosis (IPF) is a type of…
Challenges in the rare diseases' space
Rare diseases are a large group of diseases that affect a very small percentage…